We are live on ! Find out more
IDXX icon

Idexx Laboratories
IDXX

924 hedge funds and large institutions have $24B invested in Idexx Laboratories in 2022 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 336 increasing their positions, 352 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.66% more ownership

Funds ownership: 87.87% → 88.53% (+0.66%)

5% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 352

3% less funds holding

Funds holding: 956 → 924 (-32)

7% less capital invested

Capital invested by funds: $25.9B → $24B (-$1.87B)

14% less funds holding in top 10

Funds holding in top 10: 21 → 18 (-3)

21% less call options, than puts

Call options by funds: $91.6M | Put options by funds: $116M

29% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 85

Holders
924
Holders Change
-32
Holders Change %
-3.35%
% of All Funds
15.92%
Holding in Top 10
18
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-14.29%
% of All Funds
0.31%
New
60
Increased
336
Reduced
352
Closed
85
Calls
$91.6M
Puts
$116M
Net Calls
-$24.7M
Net Calls Change
-$22.2M

Top Buyers

1
Principal Financial Group
Principal Financial Group
Iowa
+$222M
2
BlackRock
BlackRock
New York
+$132M
3
Citadel Advisors
Citadel Advisors
Florida
+$97M
4
Brown Advisory
Brown Advisory
Maryland
+$62.8M
5
ESCM
Echo Street Capital Management
New York
+$61.4M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$241M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$171M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$135M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$80.1M
5
Renaissance Technologies
Renaissance Technologies
New York
-$58.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
TSW
876
Thompson Siegel & Walmsley
Virginia
$6K – – –
VNA
877
Valley National Advisers
Pennsylvania
$6K – – –
HDIM
878
Hanson & Doremus Investment Management
Vermont
$5K -$3.67K -10 -40%
SC
879
Schubert & Co
Texas
$5K -$735 -2 -13%
MIM
880
Macroview Investment Management
Maryland
$5K – – –
IRC
881
Investors Research Corp
Georgia
$5K +$2.57K +7 +100%
EC
882
EdgeRock Capital
Colorado
$5K +$5.14K +14 New
TFA
883
Transamerica Financial Advisors
Florida
$4K – – –
CA
884
Clearstead Advisors
Ohio
$3K -$555K -1,511 -99%
ETC
885
Exchange Traded Concepts
Oklahoma
$3K -$321K -873 -99%
MWM
886
Mascoma Wealth Management
New Hampshire
$3K -$2.94K -8 -50%
PWMG
887
Prestige Wealth Management Group
New Jersey
$3K -$1.47K -4 -29%
APC
888
Aspire Private Capital
North Carolina
$3K – – –
GWSG
889
GPS Wealth Strategies Group
Colorado
$3K – – –
HFM
890
Hartford Financial Management
Connecticut
$3K – – –
JWM
891
Janiczek Wealth Management
Colorado
$3K – – –
LFG
892
Larson Financial Group
Missouri
$3K – – –
MUMSS
893
Mitsubishi UFJ Morgan Stanley Securities
Japan
$3K – – –
TJHA
894
Thomas J. Herzfeld Advisors
Florida
$3K – – –
TSWM
895
Tyler-Stone Wealth Management
Ohio
$3K – – –
JFGIW
896
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$3K +$2.57K +7 +233%
AIP
897
Almanack Investment Partners
Pennsylvania
$3K +$2.94K +8 New
AWM
898
Atticus Wealth Management
Florida
$2K – – –
DI
899
Disciplined Investments
Oklahoma
$2K – – –
FWM
900
Focused Wealth Management
New York
$2K – – –
34 35
36
37 38

IDXX Hedge Fund Activity: Q3 2022 in Review

924 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2022, worth a combined $24B — down 7.2% from $25.9B a quarter earlier.

Sellers outnumbered buyers: 85 funds closed out of IDXX and 60 opened new positions — a net loss of 25 holders — while 352 trimmed existing stakes and 336 added.

The largest buyer was Principal Financial Group, adding an estimated $222M. The largest seller was T. Rowe Price Associates, cutting an estimated $241M.

  • 924 institutional investors held Idexx Laboratories (IDXX) as of Q3 2022, down from 956 in Q2 2022.
  • Funds reported $24B of Idexx Laboratories stock for Q3 2022, down 7.2% quarter-over-quarter.
  • 60 funds opened new Idexx Laboratories positions in Q3 2022 and 85 closed out, a net change of -25 holders.
  • The largest Idexx Laboratories buyer in Q3 2022 was Principal Financial Group, an estimated $222M added.
  • The largest Idexx Laboratories seller in Q3 2022 was T. Rowe Price Associates, an estimated $241M sold.

Based on aggregated 13F filings for Q3 2022.